Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

77 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q3 2024.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13,910,387 shares of 43,411,663 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include Bleichroeder LP (4,997,240 shares), Slate Path Capital LP (2,402,455 shares), VANGUARD GROUP INC (2,031,421 shares), BlackRock, Inc. (570,975 shares), GEODE CAPITAL MANAGEMENT, LLC (508,827 shares), Robertson Stephens Wealth Management, LLC (478,500 shares), Sigma Planning Corp (401,325 shares), Good Life Advisors, LLC (400,000 shares), MILLENNIUM MANAGEMENT LLC (358,974 shares), and GSA CAPITAL PARTNERS LLP (291,663 shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.